Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
Tweet | ||
282 * ! | Tue, 8/5/2014, 8:30 AM - 10:20 AM | CC-156A | |
Challenges in Analyzing and Interpreting Multiple (Possibly Censored) Outcomes in Chronic Disease Trials — Topic Contributed Papers | |||
Biometrics Section | |||
Organizer(s): Dianne M. Finkelstein, Massachusetts General Hospital/Harvard University | |||
Chair(s): Brian Healy, Massachusetts General Hospital | |||
8:35 AM | Introduction: Issues in Multiple outcomes in clinical trails when they are ordered or simultaneous and possibly censored — Dianne M. Finkelstein, Massachusetts General Hospital/Harvard University | ||
8:55 AM | Case Study on Interpretation of Progression-Free Survival and Overall Survival in a Trial with Treatment Crossover: Tivozanib in Renal Cancer — Andrew Strahs, Alnylam Pharmaceuticals | ||
9:15 AM | A Generalized Global Rank Test for Multiple, Possibly Censored, Outcomes — Ritesh Ramchandani, Harvard ; Dianne M. Finkelstein, Massachusetts General Hospital/Harvard University ; David Alan Schoenfeld, Massachusetts General Hospital | ||
9:35 AM | Comparing and Summarizing Multiple Outcomes in a Clinical Trial — Marc Buyse, IDDI | ||
9:55 AM | Discussant: David Alan Schoenfeld, Massachusetts General Hospital | ||
10:15 AM | Floor Discussion |
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.